Dockets
Recently active federal rulemakings, soonest-closing first.
Open for comment
Agency ▾
All agenciesACF (33)ACL (2)AHRQ (2)AID (12)AMS (143)APHIS (134)ARS (1)ASC (33)ATBCB (14)ATF (35)ATR (4)ATSDR (7)BIA (9)BIS (87)BLM (48)BLS (4)BOEM (122)BOP (9)BOR (1)BPA (1)BSC (21)BSEE (30)CCC (5)CDC (182)CDFI (8)CEQ (5)CFPB (104)CFTC (27)CISA (36)CMS (495)CNCS (42)COE (14)COLC (9)CPPBSD (22)CPSC (87)CSB (1)DARS (70)DEA (339)DEPO (2)DHS (112)DOC (6)DOD (237)DOE (135)DOI (80)DOJ (30)DOL (15)DOS (2045)DOT (849)EAB (1)EAC (27)
- 0 documents · 0 comments
- 0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Ohana Bio Pharma, LLC DEA1523DEANonrulemaking0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals DEA1521DEANonrulemaking0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Baxter Research Lab DEA1519DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Royal Beverages, LLC DEA1524DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- Importer of Controlled Substances Application: Scottsdale Research Institute DEA1527DEANonrulemaking0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Patheon API Services Inc. DEA1529DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals DEA1523DEANonrulemaking0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC; Correction DEA1512DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories Inc DEA1534DEANonrulemaking0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc. DEA1518DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- Importer of Controlled Substances Application: Almac Clinical Services Inc (ASCI) DEA1537DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- Importer of Controlled Substances Application: United States Pharmacopeial Convention DEA1538DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- 0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc. DEA1547DEANonrulemaking0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc DEA1552DEANonrulemaking0 documents · 0 comments
- Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146)DEARulemaking0 documents · 0 comments
- 0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem DEA1558DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services DEA1553DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- Importer of Controlled Substances Application: Arizona Department of Corrections DEA1560DEANonrulemaking0 documents · 0 comments
- Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation DEA1563DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments
- Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services DEA1568DEANonrulemaking0 documents · 0 comments
- 0 documents · 0 comments